155 related articles for article (PubMed ID: 10644944)
21. Mortality and cancer incidence following radiotherapy for seminoma of the testis.
Horwich A; Bell J
Radiother Oncol; 1994 Mar; 30(3):193-8. PubMed ID: 8209001
[TBL] [Abstract][Full Text] [Related]
22. Radiotherapy for stages I and II testicular seminoma: results and morbidity in 238 patients.
Vallis KA; Howard GC; Duncan W; Cornbleet MA; Kerr GR
Br J Radiol; 1995 Apr; 68(808):400-5. PubMed ID: 7795977
[TBL] [Abstract][Full Text] [Related]
23. Management of clinical stage I testicular pure seminoma. Report on 42 patients and review of the literature.
Porcaro AB; Antoniolli SZ; Schiavone D; Maffei N; Bassetto MA; Curti P
Arch Ital Urol Androl; 2002 Jun; 74(2):77-80. PubMed ID: 12161941
[TBL] [Abstract][Full Text] [Related]
24. Short course para-aortic radiation for stage I seminoma of the testis.
Logue JP; Harris MA; Livsey JE; Swindell R; Mobarek N; Read G
Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1304-9. PubMed ID: 14630266
[TBL] [Abstract][Full Text] [Related]
25. Long term results and morbidity of paraaortic compared with paraaortic and iliac adjuvant radiation in clinical stage I seminoma.
Melchior D; Hammer P; Fimmers R; Schüller H; Albers P
Anticancer Res; 2001; 21(4B):2989-93. PubMed ID: 11712799
[TBL] [Abstract][Full Text] [Related]
26. Cytogenetic follow-up in testicular seminoma patients exposed to adjuvant radiotherapy.
Gamulin M; Kopjar N; Grgić M; Ramić S; Viculin T; Petković M; Garaj-Vrhovac V
Coll Antropol; 2010 Jun; 34(2):455-65. PubMed ID: 20698117
[TBL] [Abstract][Full Text] [Related]
27. Testicular radiation for primary seminoma in a solitary testis.
Chung PW; Jewett MA; Warde PR
Can J Urol; 2006 Feb; 13(1):2975-7. PubMed ID: 16515752
[TBL] [Abstract][Full Text] [Related]
28. Mortality after cure of testicular seminoma.
Zagars GK; Ballo MT; Lee AK; Strom SS
J Clin Oncol; 2004 Feb; 22(4):640-7. PubMed ID: 14726503
[TBL] [Abstract][Full Text] [Related]
29. Radiotherapy for stage I seminoma of the testis: Organ equivalent dose to partially in-field structures and second cancer risk estimates on the basis of a mechanistic, bell-shaped, and plateau model.
Mazonakis M; Varveris C; Lyraraki E; Damilakis J
Med Phys; 2015 Nov; 42(11):6309-16. PubMed ID: 26520723
[TBL] [Abstract][Full Text] [Related]
30. Second tumors after radiation treatment of testicular germ cell tumors.
Oliver RT
J Clin Oncol; 1993 Nov; 11(11):2286-7. PubMed ID: 8229145
[No Abstract] [Full Text] [Related]
31. Excellent long-term disease control with modern radiotherapy techniques for stage I testicular seminoma--the Mayo Clinic experience.
Hallemeier CL; Choo R; Davis BJ; Leibovich BC; Costello BA; Pisansky TM
Urol Oncol; 2014 Jan; 32(1):24.e1-6. PubMed ID: 23490907
[TBL] [Abstract][Full Text] [Related]
32. Stage I testicular seminoma: results of adjuvant irradiation and surveillance.
Warde P; Gospodarowicz MK; Panzarella T; Catton CN; Sturgeon JF; Moore M; Goodman P; Jewett MA
J Clin Oncol; 1995 Sep; 13(9):2255-62. PubMed ID: 7666083
[TBL] [Abstract][Full Text] [Related]
33. Angiosarcoma following treatment of testicular seminoma: case report and literature review.
Lee KC; Yeung K; Welsh C; Katzen H; Haidak D
J Urol; 1995 Mar; 153(3 Pt 2):1055-6. PubMed ID: 7853561
[TBL] [Abstract][Full Text] [Related]
34. Outcomes in stage I testicular seminoma: a population-based study of 9193 patients.
Beard CJ; Travis LB; Chen MH; Arvold ND; Nguyen PL; Martin NE; Kuban DA; Ng AK; Hoffman KE
Cancer; 2013 Aug; 119(15):2771-7. PubMed ID: 23633409
[TBL] [Abstract][Full Text] [Related]
35. Squamous cell carcinoma of the renal pelvis after curative retroperitoneal radiotherapy for seminoma.
O'Daly BJ; O'Brien MF; Dowling CM; Crotty TB; Watson AJ; Moriarty MJ; Mulvin DW
Urology; 2007 Oct; 70(4):812.e3-6. PubMed ID: 17991576
[TBL] [Abstract][Full Text] [Related]
36. Second malignancies following radiotherapy for testicular seminoma.
Steinfeld AD; Shore RE
Clin Oncol (R Coll Radiol); 1990 Sep; 2(5):273-6. PubMed ID: 2261427
[TBL] [Abstract][Full Text] [Related]
37. A risk-adapted strategy of radiotherapy or cisplatin-based chemotherapy in stage II seminoma.
Domont J; Massard C; Patrikidou A; Bossi A; de Crevoisier R; Rose M; Wibault P; Fizazi K
Urol Oncol; 2013 Jul; 31(5):697-705. PubMed ID: 21665493
[TBL] [Abstract][Full Text] [Related]
38. Management of testicular seminoma advanced disease. Report on 14 cases and review of the literature.
Porcaro AB; Antoniolli SZ; Maffei N; Beltrami P; Bassetto MA; Curti P
Arch Ital Urol Androl; 2002 Jun; 74(2):81-5. PubMed ID: 12161942
[TBL] [Abstract][Full Text] [Related]
39. Second cancer risk and mortality in men treated with radiotherapy for stage I seminoma.
Horwich A; Fossa SD; Huddart R; Dearnaley DP; Stenning S; Aresu M; Bliss JM; Hall E
Br J Cancer; 2014 Jan; 110(1):256-63. PubMed ID: 24263066
[TBL] [Abstract][Full Text] [Related]
40. Increased incidence of sarcoma in patients treated for testicular seminoma.
Jacobsen GK; Mellemgaard A; Engelholm SA; Møller H
Eur J Cancer; 1993; 29A(5):664-8. PubMed ID: 8471322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
